Frequently asked questions

I'm a practitioner. What can I expect from Miro?


Miro allows you to assign your patients specialty neurobehavioral assessments for Alzheimer's disease and related disorders, late-life depression, mild cognitive impariment, stroke, or traumatic brain injury. A doctor at Miro interprets the results, writes a report, and proposes a care plan. The interpreted results and care plan are sent to the patient's EMR where you can view them.




How do patients interact with Miro?


Miro emails patients and guides them through web-based questionnaires and a downloadable mobile application with self-administrable cognitive, behavioral, and psychiatric assessments. Miro provides patients with non-medical feedback. Miro's full battery is available on the iPad. Limited batteries are available by iPhone and Android ( coming soon).




I'm an independent practitioner, how do I use Miro in my practice?


Miro is limiting clinical use to our Early Partners Program, only. View details about Miro's Early Partners Program




I'm a practitioner within a healthcare organization, how can I use Miro?


Check with your organization to understand their policy on the use of new devices. You may be able to use Miro independently, or it may be that you can only use Miro if your organization uses Miro. Contact a Miro representative




Has Miro been approved by the FDA?


Miro has been designated by the FDA as a Breakthrough Device. Miro is available for automated assessment and results calculation. Miro results must currently be interpreted by a specialty clinical practitioner at Miro. Miro is conducting pivotal studies for FDA Clearance as a stand-alone diagnostic for MCI including automated results interpretation.




What is Miro's Intended Use


Remote assessment and interpreted reports of cognitive, neurological, and psychiatric function; collaborative care plans; status monitoring




What are Miro's Indications?


Age 65+

  1. The diagnosis of Mild Cognitive Impairment (MCI)
  2. Differential diagnostic support and care planning for brain conditions including: MCI, stroke, cancer, depression, Alzheimer’s disease and related disorders (ADRD), Parkinson’s spectrum disorders (PSD), aphasia, traumatic brain injury/ concussion, and other brain-affecting conditions




Where does Miro sit in the care continuum?


  1. Preventive brain healthcare
  2. MCI diagnosis
  3. Differential diagnostic support
  4. Care planning
  5. Ongoing status monitoring




What are Miro's benefit categories?


  1. Telemedicine
  2. Preventive services and chronic disease management
  3. Emergency brain health services
  4. Ambulatory brain health services
  5. Rehabilitative brain health services




Are there alternatives to using Miro?


The FDA determined that no predicate devices exist for Miro. However, Miro assesses the motor, speech, language, cognitive, and emotional functions that are typically performed in one-on-one visits by doctors.




What evidence has been generated to prove Miro's validity?


Evidence generated demonstrates

  1. Concurrent validity
  2. Construct Validity
  3. Test Retest Reliability
  4. Sensitivity and Specificity for MCI
  5. Positive Predictive Value for MCI
  6. Negative Predictive Value for MCI Publications include Sloan et al., Clinical Neurology
Publications Sloan et al., Clinical Neurology Practice. 2020. Miro v3.0 2020, submitted [ Miro White Paper 2017. Miro v2.0 ] Miro Abstract 2014. Miro v1.0 [ View list of Miro's Clinical Studies]





  • Frame 25
  • Frame 26
  • Frame 35
appstore-aaf345f67a67888a4c00c42b1f5d759

COMPANY

PRODUCT

QUESTIONS